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A simple reversed-phase HPLC method for measuring hepatic levels of acetaminophen- (APAP-) protein adduct following an
overdose of APAP was developed. An aliquot of liver homogenate in phosphate-buﬀered saline pH 7.4 (PBS) was placed on a
Nanosep centrifugal device, which was centrifuged to obtain a protein residue. This residue was incubated with a solution of p-
aminobenzoic acid (PABA), the internal standard, and bacterial protease in PBS, transferred to a Nanosep centrifugal device, and
centrifuged. A 100µL portion of the ﬁltrate was analyzed on a YMC-Pack ODS-AMQ C18 column, using 100mM potassium
dihydrogen phosphate-methanol-acetic acid (100:0.6:0.1) as the mobile phase, a ﬂow rate of 1mL/min, and photometric
detection at 254nm. PABA and APAP-cystein-S-yl (APAP-Cys) eluted at ∼14.7min and 22.7min, respectively. Method linearity,
based on on-column concentrations of APAP-Cys, was observed over the range 0.078–40µg. Recoveries of APAP-Cys from spiked
blank liver homogenates ranged from ∼83% to 91%. Limits of detection and of quantiﬁcation of APAP-Cys, based on column
concentrations, were 0.06µg and 0.14µg, respectively. RSD values for interday and intraday analyses of a blank liver homogenate
spiked with APAP-Cyst at three levels were, in all cases, ≤1.0% and <1 . 5 % ,r e s p e c t i v e l y .T h ep r o p o s e dm e t h o dw a sf o u n d
appropriate for comparing the antidotal properties of N-acetylcysteine and taurine in a rat model of APAP poisoning.
1.Introduction
In addition to being the most common analgesic and antipy-
retic agent worldwide, acetaminophen (N-acetyl-p-amino-
phenol, APAP) is also regarded as a leading cause for inten-
tional or unintentional overdosing, for severe hepatotoxicity
and for acute live failure (ALF) in the United States and the
United Kingdom [1,2]. One of thecritical contributorysteps
to the hepatotoxicity that follows the ingestion of overdoses
of APAP is its initial oxidative metabolism to N-acetyl-p-
benzoquinoneimine (NAPQI) by hepatic cytochrome P450
isoforms and subsequent covalent binding of this reactive
metabolite to hepatic cytosolic and organelle proteins, pri-
marily, though, not exclusively, to cysteine residues to
generate stable 3-(cystein-S-yl)acetaminophen (APAP-Cys)
adducts [3]. The extent to which APAP binds to hepatic
proteins is of clinical interest since it reﬂects the severity of
its dose-related damaging action on the liver, especially to
centrilobular cells [4] and is a way to improve diagnostic
accuracy in patients with ALF [5]. Analytical methods pres-
entlyavailabletomeasureAPAPcovalentlyboundtoproteins
in the liver and serum have included an avidin-biotin am-
pliﬁed competitive enzyme-linked immunosorbent (A-B
ELISA) assay [6, 7], an immunoblot technique using anti-
serum speciﬁc for APAP-CYS and imaging densitometry
[8, 9], and a high-performance liquid chromatography with
coulometric electrochemical detection (HPLC-ECD) [5, 10].
While the A-B ELISA and immunoblot techniques require
multiple procedural steps and reagents and an antiserum
speciﬁc for APAP-Cys that is not readily available, the HPLC-
ECD method relies on a lengthy dialysis step to separate
protein-bound APAP from any interfering amino acids,2 The Scientiﬁc World Journal
unbound APAP, or free APAP-Cys and on an electrochemical
detection setup that may not be available in the average lab-
oratory. A more recently published liquid chromatographic
method coupled with tandem mass spectrometric has only
been evaluated as a qualitative tool for detecting the binding
of APAP to serum albumin [11].
In comparison with currently available analytical meth-
ods for measuring APAP-protein conjugates in biological
samples, the HPLC method with photometric detection de-
scribed in the present report is methodologically simpler,
requiring less procedural steps, and using readily available
reagents. The sample preparation has been greatly simpliﬁed
by utilizing centrifugal ultraﬁltration to initially isolate
APAP-protein adducts, and, subsequently, the APAP-Cys
fragments liberated by enzymatic hydrolysis from their an-
choring proteins. The method has been found to be speciﬁc,
reproducible, and with the required sensitivity to detect the
levels of APAP-Cys associated with an overdose of APAP.
Using the rat as an experimental model, the proposed HPLC
methodwasfoundtobenotonlyusefulformeasuringAPAP-
proteinadductsintheliverbutalsoforassessingtheantidotal
eﬀectiveness of model compounds against APAP-induced
hepatotoxicity due to a toxic dose of APAP.
2. Experimental
2.1. Materials and Solvents. APAP, p-aminobenzoic acid
(PABA), potassium dihydrogen phosphate, and protease
(Pronase E, type XIV from Streptomyces griseus, 4units/mg
of solid) were purchased from Sigma-Aldrich, St. Louis, MO,
USA. 3-Cysteinylacetaminophen (APAP-Cys) triﬂuoroacetic
acid salt was purchased from Toronto Research Chemicals
Inc., North York, ON, Canada. HPLC-grade methanol,
HPLC-grade water, perchloric acid (70%, w/v), and glacial
acetic acid were purchased from J. T. Baker, Phillipsburg, NJ,
USA. Nanosep centrifugal device with Omega ultraﬁltration
membrane molecular weight cutoﬀ 30kDa, red type, was
from Pall Corporation, East Hills, NY, USA; and high-grade
regenerated cellulose tubular dialysis membrane (Cellu-Sep
H1, nominal MWCO 3500) was from Membrane Filtration
Products, Inc., Seguin, TX, USA.
2.2. HPLC System. Chromatographic analyses were carried
out on a Waters Alliance HPLC system consisting of the
2695 Separations Module, 2998 photodiode array detector
and 2707 autosampler (Waters Corporation, Milford, MA,
USA). The chromatograms were acquired with an Empower
Chromatography Software (Waters Corporation, Milford,
MA, USA).
2.3.ChromatographicConditions. Thechromatographicsep-
arations were achieved on an YMC-Pack ODS-AMQ C18,
150 × 4.6mm i.d., 5µm, column (Waters Corporation,
Milford, MA, USA). The mobile phase was a mixture of
100mM potassium dihydrogen phosphate-methanol-acetic
acid (100:0.6:0.1, by volume), pH 4.7 ± 0.2, ﬁltered
in vacuo through a 0.45µm membrane ﬁlter (Millipore,
Bedford, MA, USA), and degassed by sonication prior to use.
T h em o b i l ep h a s ew a sd e l i v e r e da tar a t eo f1 m L / m i n .A
100µL volume of sample was injected from an autosampler
kept at 4◦C. The detection wavelength was 254nm.
2.4. Solutions
2.4.1. Protease Solution. This solution was prepared by dis-
solving a sample of lyophilized, powdered, bacterial protease
in phosphate-buﬀered saline (PBS) pH 7.4 to obtain a so-
lution containing 8 units per mL.
2.4.2. PABA Solution. This solution was prepared by dissolv-
ingasampleofPABA,theinternalstandard,indistilledwater
to obtain a solution containing 1mg/mL.
2.5. Validation of the Method
2.5.1. Linearity and Recovery. The linearity of the proposed
HPLC method was assessed by preparing two calibration
curves, one in protein matrix and one in distilled water,
from serial dilutions of an aqueous APAP-Cys stock solution
(1mg/mL). The protein matrix was obtained by placing
0.5mL aliquots of a homogenate made from the liver of a
rat treated only with 50% PEG on individual conditioned
30kDa Nanosep centrifugal device (previously conditioned
by wetting with 0.2mL of distilled water and followed
by drying by centrifugation at 12.000×g for 10min) and
subjecting the devices to centrifugation at 12.000×gf o r
10min. The retained protein residues were quantitatively
dislodged from the membranes by using 100µL aliquots of
distilled water, and all the washings were pooled together
until a 4mL volume of matrix protein dispersion had been
collected.Theentirevolumeofmatrixproteindispersionand
anequalvolumeofdistilledwaterwereseparatelymixedwith
250µL of PABA solution and 250µL of protease solution.
A 400µL volume of each reaction mixture was mixed with
100µL of APAP-Cys solution, and each type of solution
was serially diluted, respectively, with blank stock matrix
protein dispersion or distilled water to obtain concentrations
of APAP-Cys in the range 1.562–200µg/mL. Following their
incubation at 50◦C for 16hr, the dilutions were ﬁltered
through 0.45µm membrane ﬁlters, and a 100µLa l i q u o to f
each ﬁltrate was injected into the liquid chromatograph in
duplicate.
The percentage (%) recovery of APAP-Cys from protein
matrix was calculated from the peak area ratios gathered
in the linearity study. To this eﬀect, the peak area ratios at
each dilution for samples prepared in protein matrix were
related to those in water. Assuming the peak area ratios for
solutions in water to represent 100% recovery, the recovery
of APC-Cys from liver matrix protein at each level studied
(as a percentage of the peak responses for samples in distilled
water) was calculated using the equation (peak area ratio in
matrix protein/peak area ratio in water) × 100.
2.5.2. Investigation of the Isolation of APAP-Protein Adducts
from Liver Homogenates. Based on the peak area response
obtained for an aqueous 10µg/mL solution of APAP-Cys
put through the sample preparation steps used in the lin-
earity test and representing 100% recovery, three sampleThe Scientiﬁc World Journal 3
preparation approaches were examined to determine which
one yielded the highest recovery. For this purpose, 100µL
aliquotsofastocksolutionofAPAP-Cyscontaining1mg/mL
were added to 400µL of an incubation mixture obtained by
one of three diﬀerent approaches. The ﬁrst approach was a
centrifugal ultraﬁltration method in which 4mL of matrix
protein obtained as described for the method linearity study
was treated in the exactly the same manner as for a dilution
sample containing a ﬁnal concentration of APAP-Cys of
10µg/mL in matrix protein. The second approach was a
precipitation method whereby a 4mL aliquot of drug-free
liver homogenate, prepared in phosphate-buﬀered saline
(PBS) pH 7.4 in a ratio of 1g in 5mL, was mixed with 400µL
of 10% perchloric acid and centrifuged at 12.000×ga n d4 ◦C
for 20min to obtain a protein pellet. This pellet was washed
with two 200µL portions of water, resuspended in 4mL of
3M urea in PBS pH 8.0, and subjected to sonication in an
ultrasonicbathuntilauniformdispersionwasobtained.This
suspension was then processed as described in the linearity
study and starting with the consecutive addition of a PABA
solution and a protease solution. The third approach was
a dialysis method in which a 4mL aliquot of drug-free
liver homogenate, prepared in PBS pH 7.4 using a ratio of
1g in 5mL, was placed in a Cellu-Sep H1 tubular dialysis
membrane and dialyzed three time against 1000mL portions
of sodium acetate buﬀer pH 6.5 for periods of 12hr each.
The contents of the dialysis bag were transferred to 4mL of
acetate buﬀer pH 6.5, and the dispersion was next processed
as described in the linearity study and starting with the
addition of PABA solution and protease solution.
2.5.3. Intraday and Interday Precision. Samples of APAP-Cys
in matrix protein dispersion, prepared as described for the
linearity and recoverystudy and containing 0.156, 0.625, and
1.25µg of analyte per 100µL, were injected at three diﬀerent
timesinthesamedaytocheckforintradayreproducibilityor
at the same time in three separate days to check for interday
reproducibility.
2.6. Animal Studies. Groups of 6 male Sprague-Dawley rats,
200–225g in weight, were maintained on a normal rat
chow and ﬁltered tap water for 3 days following their ar-
rival. Following a 12hr fasting overnight, the animals re-
ceivedasingleintraperitoneal(i.p.),800mg/kg/2mL,doseof
an APAP solution (100mg/mL) in 50% PEG 400. Ani-
mals treated with an APAP antidote received either N-
acetylcysteine(NAC)ortaurine(TAU)inphysiologicalsaline
by the i.p. route, in a 2.4mmol/kg/2mL dose, 30min before
APAP. Control animals received only 50% PEG 400 (2mL)
followed 30min later by water (2mL). After 6hr, all the
animals were sacriﬁced by decapitation, and their livers
were freeze clamped, surgically excised, and placed in liquid
nitrogen until needed.
2.7. Liver Sample Preparation. A 1g portion of frozen liver
was mixed with 5mL of PBS pH 7.4 and homogenized for
30sec with a hand-held electric tissue homogenizer while
kept immersed in an ice bath. The resulting suspension
was centrifuged at 12.000×ga n d4 ◦Cf o r2 0 m i n ,a n da
500µL aliquot of the supernatant was placed on a Nanosep
centrifugal device with a membrane molecular weight cutoﬀ
of 30kDa (previously conditioned by wetting with 200µLo f
distilled water and drying by centrifugation at 12,000×gf o r
10min) and the device centrifuged at 12.000×g for 10min.
The protein retained on the membrane was washed three
t i m e sw i t h1 0 0µL portions of distilled water, with centrifu-
gation at 12.000×g for 10min after each washing, and then
quantitatively dislodged from the membrane with the aid
of a spatula and 100µL portions of distilled water until a
400µL volume of protein dispersion had been collected. This
protein dispersion was mixed, in succession, with 25µLo f
PABA solution (1mg/mL) and 25µLo fp r o t e a s es o l u t i o n( 8
units/mL), and then incubated at 50◦C for 16hr on a heating
block. The digest was transferred to a conditioned Nanosep
centrifugal device and centrifuged at 12.000×gf o r1 0m i n
to collect the ﬁltrate. The membrane on the ﬁltration device
was rinsed twice with 100µL portions of distilled water, and
the washings and ﬁltrate were pooled together and brought
to a ﬁnal volume of 700µL with additional distilled water.
A 100µL aliquot of this solution was injected into the liquid
chromatograph.
2.8. Data Analysis. The experimental results for the animal
study are reported as the mean ± SEM for n = 6. Statistical
comparisons were carried out using Student’s t-test followed
by one-way analysis of variance (ANOVA) and Tukey’s
test for multiple comparisons. Calculations were performed
using a commercially available statistical software program
(JMP 8 from SAS Institute Inc., Cary, NC, USA). Diﬀerences
were considered to be signiﬁcant when P<0.05.
3. Results and Discussion
3.1. Isolation of APAP-Protein Conjugates. The most appro-
priate conditions to isolate APAP bound to hepatic proteins
via the sulfhydryl side chains of cysteine residues from the
liverofanimalsthathadbeentreatedwithasupratherapeutic
(800mg/kg) of APAP were investigated using three general
approaches: dialysis, chemical precipitation with a depro-
teinizing solution, and centrifugal ultraﬁltration. In each
case, the isolated APAP-protein conjugates were subjected
to digestion with microbial protease, and the quantity of
APAP-Cys thus liberated was measured by the proposed
HPLC method. The results originating from these three
experiments, carried out in triplicate, are graphically shown
in Figure 1.
According to the sample preparation method described
by Muldrew et al. [10], a 1:10 liver homogenate in 10mM
sodium acetate pH 6.5 is centrifuged at 16.000×ga n d
dialyzed against a large volume (4L) of the homogenizing
medium using a dialysis membrane with a molecular mass
cutoﬀ of 3500Da. Subsequently, the contents of the dialysis
bag are precipitated with 40% trichloroacetic acid, rinsed
withdisodiumphosphatepH7.4,andresuspendedin10mM
sodium acetate pH 6.5. In addition to the need for replacing
the dialyzing medium twice (at 9 and 21hr) and, hence,
large volumes of dialyzing medium, this technique requires
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Figure 1: Recovery of APAP-Cys from spiked rat liver matrix
protein dispersion by using diﬀerent methods to isolate the APAP-
protein adducts. Values are shown as the mean ± SD for three
samples. All values were compared against those obtained for an
aqueous solution of APAP-Cys, representing 100% recovery, and
where ∗P<0.01 versus aqueous solution.
recovery of APAP adduct by this method amounted to about
62% of the added amount. Although the exact reason for
this deviation from maximum recovery is at present unclear,
one potential contributory factor that will certainly require
a more detailed investigation is the type of protease used in
diﬀerentlaboratoriesto releaseAPAP-Cysfromits anchoring
proteins since the activity of diﬀerent types of protease can
vary over a wide pH range [12]. Thus, one would expect a
higher yield of APA-Cys using the present type of protease
(Pronase E from Streptomyces griseus)i nas o l u t i o nb u ﬀered
with PBS than in one buﬀered with 10mM solution of
sodium acetate since the pH of the former buﬀer (i.e., pH
7.4) is closer to the pH declared as optimal (i.e., pH 7.5) by
the supplier of this enzyme than is to that of the latter buﬀer
(i.e., pH 6.5).
In an attempt to simplify the isolation of APAP-protein
adducts from liver samples, the liver homogenate in PBS pH
7.4 was directly treated with a known protein precipitating
agent such as 10% perchloric acid in methanol. The precip-
itated proteins, separating as a pellet upon centrifugation,
were subjected to two cycles of dispersion in water followed
by centrifugation and submitted to proteolytic digestion.
Although extremely simple and fast, the recovery of APAP-
Cys adduct by this protein-separating approach was slightly
less (by ∼3.7%) than that by dialysis (Figure 1), possibly
because of the degree of compactness of the protein pellet
and of the traces of acid remaining with it, factors which
could have, respectively, interfered with the ability of the
protease to reach all of the APAP-protein adducts available
for proteolysis and for displaying its full hydrolyzing activity.
In the proposed method, APAP-protein adducts were
isolated from liver homogenates in PBS pH 7.4 by centrifugal
ultraﬁltration using a Nanosep centrifugal device. In essence,
this device will retain the APAP-protein adduct on the
ultraﬁltration membrane, which in this case was selected
to retain adducts having a molecular weight of 30kDa and
above. The retentive eﬃciency and, hence, the quantity of
APAP-protein adduct left on the membrane, amounted to
Table 1: Results of a recovery study of APAP-Cys from spiked a rat
liver matrix protein dispersiona,b.
Amount added (µg) Amount found (µg) Mean recovery (%)
0.078 0.065 ± 0.003 83.3
0.156 0.136 ± 0.001 87.1
0.312 0.300 ± 0.002 88.5
0.625 0.547 ± 0.002 87.5
1.250 1.108 ± 0.002 88.6
2.500 2.262 ± 0.001 90.5
5.000 4.488 ± 0.002 89.8
10.000 8.906 ± 0.001 89.1
20.000 18.129 ± 0.001 90.6
40.000 36.380 ± 0.001 91.0
aValues for amount found represent the mean ± SD for n = 3s a m p l e s .
bMean recoveries were calculated by comparing the peak area ratio
responses of spiked rat liver samples with those of equipotent samples in
distilled water and regarded as 100% recovery.
about 90.0% (Figure 1). In addition to its simplicity and
greater eﬃciency as an isolation technique, processing of
a liver homogenate by this technique could be successfully
completed in less than 1hr.
3.2. Chromatographic Conditions. Using photometric detec-
tion at 254nm, PABA, the internal standard, and APAP-CYS,
the analyte, injected as part of an aqueous mixture, were
observed to elute at about 14.5 and 23.3min, respectively,
(Figure 2(a)). A liver sample from a rat receiving only 50%
PEG 400, and put through the ultraﬁltration and proteolytic
digestion steps, showed chromatographic peaks for endoge-
nous liver components which did not interfere with the
peaksofinterest(Figure2(b)).Anidenticalchromatographic
pattern was obtained from the analysis of a liver sample
from a rat treated with a very high (800mg/kg) dose of
APAP (Figure 2(c)). Conﬁrmatory evidence on the identity
of the slower-eluting peak was obtained by spiking the same
liver sample with authentic APAP-Cys (∼5µg/100µL) and
observing an enhancement in the size of the peak eluting at
∼23.0min (Figure 2(d)).
3.3.Linearity,Recovery,andLimitsofDetection. Thelinearity
of the proposed method was investigated by preparing two
ten-point calibration curves for APAP-Cys, one in blank liver
matrixproteinandtheotherindistilledwater.Forbothtypes
of solutions, a linear correlation between peak area responses
at254nmandon-columnconcentrationsofAPAP-Cysinthe
range 0.078–40.000µg was observed.
By relating the peak area responses derived from solu-
tions of APAP-Cys in blank liver matrix protein with those
from solutions in distilled water, taken as 100% recovery, it
was veriﬁed that the recovery of APAP-Cys, for on-column
concentrations from 0.078 to 40.000µg, ranged from ∼83%
to ∼91.0% of the added amount (see Table 1). The linear
equations and corresponding coeﬃcient of determination
(r2) values for solutions of APAP-Cys in liver matrix protein
and in distilled were, respectively, y = 0.0317x−0.005 (r2 =The Scientiﬁc World Journal 5
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Figure 2: Chromatograms of (a) a liver sample from a rat treated only with physiological saline; (b) a rat liver extract spiked with APAP-Cys
(2.5µg/100µL) and PABA, the internal standard; (c) a liver extract from a rat treated with APAP (800mg/kg i.p.); (d) a liver extract from a
rattreated withAPAP(800mg/kgi.p.)andspikedexvivowithauthenticAPAP-Cys(2.5µg/100µL of liver extract).Key: 1,PABA,theinternal
standard; 2, APAP-Cys adduct.
0.9996) and y = 0.0349x − 0.0037 (r2 = 0.998). The lowest
concentrations of APAP-Cys that could be detected (i.e.,
limit of detection) and accurately measured (i.e., limit of
quantiﬁcation)bytheproposedmethodamountedto0.06µg
and 0.14µg (on column), respectively, at a signal-to-noise
ratio of at least 2:1.
3.4. Precision and Accuracy. Intraday variability was assessed
by using the proposed method to analyze samples of APAP-
Cys, added as a spike to distilled water and to liver matrix
protein, at three diﬀerent levels (i.e., 0.156, 0.625, 1.250µg)
and at three diﬀerent times within the same day. As shown
in Table 2, the RSD values ranged from 0.52 to 0.91% for
samples in water and from 0.63% to 1.02% for samples in
matrixprotein.Evaluationofmethodinterdayvariabilitywas
carried out using the sample solutions used in the intraday
variability study. In this case, each sample solution was
analyzed once daily, for three consecutive days. As shown in
Table 3, the RSD values for samples in water and in matrix
p r o t e i nw e r ei nt h er a n g e0 . 6 0t o0 . 8 7 %a n d1 . 0 5t o1 . 3 2 % ,
respectively.
3.5.TissueSampleAnalysistoEvaluatetheEﬀectofAPAPAnti-
d o t e so nA P A P - C y sF o r m a t i o n .To test the suitability of the
proposed HPLC method for measuring the levels of APAP-
Cys adduct formation in the liver in the course of evaluating
pharmacological agents with potential for use as antidotes
against APAP overdose, rats were intraperitoneally treated
with a dose of APAP (800mg/kg) reported to be hepatotoxic
in this animal species [13]. Two additional groups of rats
received NAC or TAU, in a 2.4mmol/kg i.p. dose, 30min
before a treatment with APAP. While NAC is the most widely
accepted antidote for cases of APAP overdose [14, 15], TAU
Table 2: Results of the intraday variability study on the proposed
HPLC method based on three diﬀerent concentrations of APAP-
Cys added to distilled water and to blank rat liver matrix protein
dispersiona,b.
APAP-Cys injected (µg) Peak area ratio
(mean ± SD, n = 3) RSD (%)
Samples in distilled water
0.156 0.005 ± 0.002 0.91
0.625 0.021 ± 0.001 0.72
1.250 0.042 ± 0.001 0.52
Samples in rat liver matrix protein dispersion
0.156 0.004 ± 0.001 1.02
0.625 0.018 ± 0.001 0.68
1.25 00.040 ± 0.003 0.63
aEach sample was analyzed at 4hr intervals three times on the same day.
bRSD is the relative standard deviation.
has shown prophylactic and therapeutic eﬀects in APAP-
induced hepatic injury, apoptosis, and necrosis [13]. In the
absence of an antidote, a discernible peak with a retention
time (∼22.5min) comparable with that of an authentic
sample of APAP-Cys, and yielding an area equivalent to
19µg/g of liver sample, was observed at 6hr after a treatment
with APAP. In contrast, this chromatographic peak was not
detected in livers from rats treated with either NAC or TAU
ahead of APAP.
4. Conclusions
The HPLC method presented here should prove useful in
animal studies aimed at verifying the formation of APAP-
protein adducts following a treatment with a toxic dose of6 The Scientiﬁc World Journal
Table 3: Results of the interday variability study on the proposed
HPLC method based on three diﬀerent concentrations of APAP-
Cys added to distilled water and to blank rat liver matrix protein
dispersiona.
APAP-Cys injected (µg) Peak area ratio
(mean ± SD, n = 3) RSD (%)
Samples in distilled water
0.156 0.005 ± 0.002 0.87
0.625 0.020 ± 0.001 0.60
1.250 0.042 ± 0.001 0.61
Samples in rat liver matrix protein dispersion
0.156 0.004 ± 0.001 1.15
0.625 0.017 ± 0.001 1.32
1.250 0.039 ± 0.003 1.05
aEach sample was analyzed once a day for three consecutive days.
APAP as well as the eﬀect of compounds and substances with
potential for use as an antidote against APAP overdosing.
Salient features of this method are a sample preparation
approach based on centrifugal ultraﬁltration that minimizes
procedural steps and reagents and permits the isolation of
APAP-protein adducts in a rapid manner and with a high
degree of purity and yield. Except for an overnight protease
digestionstep,onecompleteanalysiscanbecompletedinless
than 2hr. Hence, the proposed method will be quite suited
in APAP-related studies with small animals and requiring the
analysis of multiple samples.
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